{"id":"75cb7b11-f05c-517f-af40-16d4c3f23d93","stable_key":"e1af6d55-ced5-56c9-9a2d-8cc2ae6ec3ff:nasunin-diabetic-bone-response","predicate":"reduced","statement":"Nasunin ameliorated bone loss in the diabetic mouse model.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"b6d4cb1a-3562-5740-aca9-c96b0e886536","mechanism_event_label":"This extends to an animal outcome, not a human clinical result.","subject":{"id":"6553997f-f098-5507-95b4-0fdb8aac491d","slug":"nasunin","display_name":"Nasunin","entity_type_key":"small_molecule"},"object":{"id":"a1ecfb73-302c-5409-9905-0e59e17f1a35","slug":"mouse-diabetic-bone-loss","display_name":"Bone loss in experimental type 2 diabetic mice","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"b6d4cb1a-3562-5740-aca9-c96b0e886536","stable_key":"e1af6d55-ced5-56c9-9a2d-8cc2ae6ec3ff:nasunin-diabetic-bone-response-event","event_type":"biochemical_relationship","label":"This extends to an animal outcome, not a human clinical result.","description":"Nasunin ameliorated bone loss in the diabetic mouse model.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6553997f-f098-5507-95b4-0fdb8aac491d","slug":"nasunin","display_name":"Nasunin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"a1ecfb73-302c-5409-9905-0e59e17f1a35","slug":"mouse-diabetic-bone-loss","display_name":"Bone loss in experimental type 2 diabetic mice","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/nasunin-research/41407214.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08\", \"start_char\": 0, \"end_char\": 1949, \"text_sha256\": \"e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Mouse transfer/ablation experiments, cell assays and virtual screening","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Nasunin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"nasunin","display_name":"Nasunin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Type 2 diabetic and control mice; mouse primary-cell models","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"This extends to an animal outcome, not a human clinical result.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Neutrophil-to-macrophage signaling and osteoclastogenesis","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"d7294ee3-9cf4-5457-ac36-919429b5859c","evidence_kind":"source_excerpt","locator":"Lines 497-508","start_line":497,"end_line":508,"excerpt":"### nasunin-diabetic-bone-response\nNasunin ameliorated bone loss in the diabetic mouse model.\nCondition category: normal\nnutrient_topic: Nasunin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: This extends to an animal outcome, not a human clinical result.\norganism: Type 2 diabetic and control mice; mouse primary-cell models\ntissue_or_cell_type: Neutrophil-to-macrophage signaling and osteoclastogenesis\nexperimental_model: Mouse transfer/ablation experiments, cell assays and virtual screening\nlimitations: New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference.\nexposure: Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract\nevidence_span: {\"source_cache\": \"artifacts/nasunin-research/41407214.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08\", \"start_char\": 0, \"end_char\": 1949, \"text_sha256\": \"e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08\"}\n[nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139","model_system":"Mouse transfer/ablation experiments, cell assays and virtual screening","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"2c43df19-ccb0-58f1-b9a4-bc92cda6de5a","stable_key":"import-e1af6d55-ced5-56c9-9a2d-8cc2ae6ec3ff","title":"Nasunin: identity, redox chemistry and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"56552c208433294bf9a6c95513d981dbe4d00fd8336c121816d7b8bd6604d50e","revision_id":"b0296d49-32d7-52dc-a23c-5e862da0fba3","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}